Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Alexandra Cohen, Najma Ahmed, Ana Sant’Anna
Intest Res. 2021;19(2):217-224.   Published online 2020 Apr 22     DOI:
Citations to this article as recorded by Crossref logo
Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn’s disease: a retrospective chart review
Phinga Do, John Andersen, Ashish Patel, Gaith Semrin, Luis Sifuentes-Dominguez, Phuong Luu, Bhaskar Gurram
F1000Research.2021; 9: 316.     CrossRef